Hbwen
2022-07-15
这是…
Synthetic Biologics Sets 1-for-10 Reverse Stock Split
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":686089265,"tweetId":"686089265","gmtCreate":1657890635862,"gmtModify":1704868642117,"author":{"id":3557441995443761,"idStr":"3557441995443761","authorId":3557441995443761,"authorIdStr":"3557441995443761","name":"Hbwen","avatar":"https://static.tigerbbs.com/01d25e0cc29a67de031bdf2427f8c2e6","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.04.07","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":6,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>这是…</p></body></html>","htmlText":"<html><head></head><body><p>这是…</p></body></html>","text":"这是…","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/686089265","repostId":2251743220,"repostType":2,"repost":{"id":"2251743220","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1657887720,"share":"https://www.laohu8.com/m/news/2251743220?lang=&edition=full","pubTime":"2022-07-15 20:22","market":"hk","language":"en","title":"Synthetic Biologics Sets 1-for-10 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2251743220","media":"Dow Jones","summary":"By Will Feuer \n\n\n \n\n\nSynthetic Biologics Inc. said it has set a 1-for-10 reverse stock split to ensu","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n By Will Feuer \n</p>\n<pre>\n \n</pre>\n<p>\n <a href=\"https://laohu8.com/S/SYN\">Synthetic Biologics Inc</a>. said it has set a 1-for-10 reverse stock split to ensure that the company can meet the per-share price requirements to remain listed on the NYSE American. \n</p>\n<p>\n The stock will begin trading on a split-adjusted basis on July 25, the company said. The reverse stock split was authorized by the company's board on July 11. The number of outstanding common shares would be reduced to 15.8 million shares from 158.4 million shares. \n</p>\n<p>\n The stock fell nearly 14%, to 20 cents a share, in premarket trading after the announcement. \n</p>\n<pre>\n \n</pre>\n<p>\n Write to Will Feuer at Will.Feuer@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n July 15, 2022 08:22 ET (12:22 GMT)\n</p>\n<p>\n Copyright (c) 2022 Dow Jones & Company, Inc.\n</p>\n</font>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Synthetic Biologics Sets 1-for-10 Reverse Stock Split</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSynthetic Biologics Sets 1-for-10 Reverse Stock Split\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2022-07-15 20:22</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n By Will Feuer \n</p>\n<pre>\n \n</pre>\n<p>\n <a href=\"https://laohu8.com/S/SYN\">Synthetic Biologics Inc</a>. said it has set a 1-for-10 reverse stock split to ensure that the company can meet the per-share price requirements to remain listed on the NYSE American. \n</p>\n<p>\n The stock will begin trading on a split-adjusted basis on July 25, the company said. The reverse stock split was authorized by the company's board on July 11. The number of outstanding common shares would be reduced to 15.8 million shares from 158.4 million shares. \n</p>\n<p>\n The stock fell nearly 14%, to 20 cents a share, in premarket trading after the announcement. \n</p>\n<pre>\n \n</pre>\n<p>\n Write to Will Feuer at Will.Feuer@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n July 15, 2022 08:22 ET (12:22 GMT)\n</p>\n<p>\n Copyright (c) 2022 Dow Jones & Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4139":"生物科技"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2251743220","content_text":"By Will Feuer \n\n\n \n\n\nSynthetic Biologics Inc. said it has set a 1-for-10 reverse stock split to ensure that the company can meet the per-share price requirements to remain listed on the NYSE American. \n\n\n The stock will begin trading on a split-adjusted basis on July 25, the company said. The reverse stock split was authorized by the company's board on July 11. The number of outstanding common shares would be reduced to 15.8 million shares from 158.4 million shares. \n\n\n The stock fell nearly 14%, to 20 cents a share, in premarket trading after the announcement. \n\n\n \n\n\n Write to Will Feuer at Will.Feuer@wsj.com \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n July 15, 2022 08:22 ET (12:22 GMT)\n\n\n Copyright (c) 2022 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1559,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/686089265"}
精彩评论